Experts in novel medicines| Clinical Trials treatments from around the world
-
Evaluation of Nivolumab plus Docetaxel in men with Prostate CancerProstate CancerPrice available on request -
Evaluation of Parsaclisib plus Ruxolitinib in patients with Myelofibrosis who have not responded to Ruxolitinib aloneMyelofibrosisPrice available on request -
Evaluation of Tafasitamab plus Parsaclisib in patients with Non Hodgkin Lymphoma or Chronic Lymphocytic LeukemiaLeukemia or LymphomaPrice available on request -
Evaluation of Parsaclisib plus Rituximab or Obinutuzumab in patients with Lymphoma that has stopped responding to treatmentLymphomaPrice available on request -
Evaluation of Tafasitamab plus Rituximab and Lenalidomide in patients with Lymphoma that has stopped responding to treatmentLymphomaPrice available on request -
Evaluation of Parsaclisib plus Bendamustine and Rituximab in patients with Newly Diagnosed Mantle Cell LymphomaLymphomaPrice available on request